Hypothalamic obesity in children: pathophysiology to clinical management
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Hypothalamic obesity (HyOb) is a complex neuroendocrine disorder caused by damage to the hypothalamus, which results in disruption of energy regulation. The key hypothalamic areas of energy regulation are the ARC (arcuate nucleus), the VMH (ventromedial hypothalamus), the PVN (paraventriculer nuclei) and the LHA (lateral hypothalamic area). These pathways can be disrupted mechanically by hypothalamic tumors, neurosurgery, inflammatory disorders, radiotherapy and trauma or functionally as such seen in genetic diseases. Rapid weight gain and severe obesity are the most striking features of HyOb and caused by hyperphagia, reduced basal metabolic rate (BMR) and decreased physical activity. HyOb is usually unresponsive to diet and exercise. Although, GLP-1 and its anologs seem to be a new agent, there is still no curative treatment. Thus, prevention is of prime importance and the clinicians should be alert and vigilant in patients at risk for development of HyOb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346 · cited 4×
“LEP (56) Anorexigenic effect Severe obesity, hyperphagia, hypogonadism, normal height until puberty but short stature after puberty LEPR (57) Leptin signaling Severe obesity, hyperphagia, hypogonadism hypothyroidism, growth retardation (low IGF1, IGFBP3) MC4R (58) α-MSH signaling Severe obesity, increased linear growt…”
InfluentialCowley, M. A., Smith, R. G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00063-1 · Cited by 1,679
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896
Central Administration of Oleic Acid Inhibits Glucose Production and Food Intake
Obici, S., Feng, Z., Morgan, K., Stein, D., Karkanias, G., & Rossetti, L. (2002) · Diabetes · doi:10.2337/diabetes.51.2.271 · Cited by 654
Mechanism of the development of obesity in animals with hypothalamic lesions.
Brobeck, J. R. (1946) · Physiological Reviews · doi:10.1152/physrev.1946.26.4.541 · Cited by 488
Central nervous system control of metabolism
Myers, M. G., & Olson, D. P. (2012) · Nature · doi:10.1038/nature11705 · Cited by 399 · cited 11×
“LEP (56) Anorexigenic effect Severe obesity, hyperphagia, hypogonadism, normal height until puberty but short stature after puberty LEPR (57) Leptin signaling Severe obesity, hyperphagia, hypogonadism hypothyroidism, growth retardation (low IGF1, IGFBP3) MC4R (58) α-MSH signaling Severe obesity, increased linear growt…”
InfluentialThe Central Melanocortin System Can Directly Regulate Serum Insulin Levels*
Fan, W., Dinulescu, D. M., Butler, A. A., Zhou, J., Marks, D. L., & Cone, R. D. (2000) · Endocrinology · doi:10.1210/endo.141.9.7665 · Cited by 294 · cited 1×
“The studies showed that hypothalamus directly controls insulin release from beta cell (29, 30) and this regulation is achieved by central α-MSH that is transmitted through signals of the sympathetic system, vagal stimulation, and direct insulin signaling in the brain (23, 31, 32).”
Müller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., & Sörensen, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031751 · Cited by 287
Insulin and Leptin as Adiposity Signals
Benoit, S. C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.267 · Cited by 266
Features of the metabolic syndrome after childhood craniopharyngioma
Srinivasan, S., Ogle, G. D., Garnett, S. P., Briody, J. N., Lee, J. W., & Cowell, C. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030442 · Cited by 211 · cited 1×
“The children with craniopharyngioma have a greater risk for metabolic syndrome due to increased abdominal adiposity, higher fasting triglycerides, and lower HDL compared with healthy age-, sex-, BMI- and pubertal stage-matched controls (82).”
Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
Apovian, C. M., Bergenstal, R. M., Cuddihy, R. M., Qu, Y., Lenox, S., Lewis, M. S., & Glass, L. C. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.019 · Cited by 127 · cited 2×
“As a new alternative agent, analog of glucagon-like peptide-1 (GLP-1), which is an incretin hormone and is used for type 2 diabetes mellitus (T2DM) (101) holds promise.”
Müller, H. L., Handwerker, G., Gebhardt, U., Faldum, A., Emser, A., Kolb, R., & Sörensen, N. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-9012-7 · Cited by 127
Hamilton, J., Conwell, L., Syme, C., Ahmet, A., Jeffery, A., & Daneman, D. (2011) · International Journal of Pediatric Endocrinology · doi:10.1155/2011/417949 · Cited by 109 · cited 3×
“Hamilton et al. published a different trial in adolescents with HyOb and found that combined diazoxide (as another inhibitor of insulin secretion) and metformine therapy produced a reduction in weight gain and BMI decreases correlated with AUCins (97).”
InfluentialO'Gorman, C. S., Simoneau-Roy, J., Pencharz, P., MacFarlane, J., MacLusky, I., Narang, I., Adeli, K., Daneman, D., & Hamilton, J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2003 · Cited by 72
Rohner, F., Dufour, A. C., Karakash, C., Le Marchand, Y., Ruf, K. B., & Jeanrenaud, B. (1977) · Diabetologia · doi:10.1007/bf01219706 · Cited by 61 · cited 1×
“The studies showed that hypothalamus directly controls insulin release from beta cell (29, 30) and this regulation is achieved by central α-MSH that is transmitted through signals of the sympathetic system, vagal stimulation, and direct insulin signaling in the brain (23, 31, 32).”
Triiodothyronine supplementation for hypothalamic obesity
Fernandes, J. K., Klein, M. J., Ater, J. L., Kuttesch, J. F., & Vassilopoulou-Sellin, R. (2002) · Metabolism · doi:10.1053/meta.2002.35591 · Cited by 39 · cited 1×
“In three patients, significant weight loss was reported with no symptoms of hyperthyroidism (99).”
Cited by
Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389
van Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Dextroamphetamine Treatment in Children With Hypothalamic Obesity
van Schaik, J., Welling, M. S., de Groot, C. J., van Eck, J. P., Juriaans, A., Burghard, M., Oude Ophuis, S. B. J., Bakker, B., Tissing, W. J. E., Schouten-van Meeteren, A. Y. N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.845937 · Cited by 30
“This can either be due to a congenital cause, such as gene defects affecting the hypothalamic leptinmelanocortin pathway, or an acquired cause, due to (treatment of) a suprasellar tumor, trauma, or a cerebral infection (1, 4, 15).”
BackgroundKlages, K. L., Berlin, K. S., Cook, J. L., Merchant, T. E., Wise, M. S., Mandrell, B. N., Conklin, H. M., & Crabtree, V. M. (2022) · Psycho-Oncology · doi:10.1002/pon.5862 · Cited by 25
Metadata
- Authors
- Haliloglu, B., & Bereket, A.
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 28
- Issue
- 5-6
- Pages
- 503-13
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W2078320570
- Cited by
- 52
- References
- 17
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.